Literature DB >> 9384483

High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma.

S Fetscher1, W Brugger, H Bertz, G Krieger, L Kanz, R Mertelsmann, W Lange.   

Abstract

We report a case of metastatic gastrointestinal leiomyosarcoma treated with high-dose combination chemotherapy and autologous peripheral blood stem cell transplantation. After incomplete surgical resection, enteral, peritoneal and hepatic involvement remained. Postoperatively, standard-dose chemotherapy with etoposide, ifosfamide, cisplatin and epirubicine, and high-dose chemotherapy with the same agents (carboplatin replacing cisplatin) was given. Treatment was well tolerated and the patient remains in complete remission at 36+ months. We conclude that high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation may be of use as treatment for inoperable residual disease after resection of the primary lesion in gastrointestinal and other soft tissue sarcomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9384483     DOI: 10.1038/sj.bmt.1700970

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Gastrointestinal leiomyosarcomas.

Authors:  R G Casey; G P Garvey; J Ryan
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

Review 2.  Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.

Authors:  Frank Peinemann; Lesley A Smith; Carmen Bartel
Journal:  Cochrane Database Syst Rev       Date:  2013-08-07

3.  Multifocal gastric gastrointestinal stromal tumors (GISTs) with lymph node metastases in children and young adults: a comparative clinical and histomorphological study of three cases including a new case of Carney triad.

Authors:  Claudia Otto; Abbas Agaimy; Alexander Braun; Jochen Rädecke; Jens Hoeppner; Gerald Illerhaus; Martin Werner; Udo Kontny; Florian Haller
Journal:  Diagn Pathol       Date:  2011-06-10       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.